コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 circumference, blood pressure, glucose, and serum lipids.
2 ased relative proportion of omega-6 PUFAs in serum lipids.
3 ples, was now evaluated for the profiling of serum lipids.
4 exhibit global perturbations of circulating serum lipids.
5 the end of each diet period and analyzed for serum lipids.
6 nal adjustment was made for levels of BP and serum lipids.
7 may be partly mediated by effects of TFAs on serum lipids.
8 r sex, age, body mass index (BMI), and total serum lipids.
9 and pectin was attenuated by adjustment for serum lipids.
10 r hemoglobin A1c, fasting blood glucose, and serum lipids.
11 There was no difference in serum lipids.
12 ssover design trial to assess the effects on serum lipids.
13 , dietary intake (via 7-d food records), and serum lipids.
14 ement the growth phenotype in the absence of serum lipids.
15 his response independently of its effects on serum lipids.
16 r function, estrogen treatment in women, and serum lipids.
17 resistance and increased body adiposity and serum lipids.
18 the association between dietary factors and serum lipids.
19 related with any measure of insulin, or with serum lipids.
20 beta-muricholic acid as well as hepatic and serum lipids.
21 ncreased with decreasing eGFR and decreasing serum lipids.
22 change in overall fatty acid composition in serum lipids.
23 Dietary sugars influence blood pressure and serum lipids.
24 ysis as the mechanism for niacin's effect on serum lipids.
26 nfection has been clinically associated with serum lipid abnormalities, yet our understanding of the
28 hoblastic leukemia treatment arm, body mass, serum lipids, albumin and cortisol levels, dexamethasone
30 e, obesity, diabetes, hypertension, smoking, serum lipids, alcohol intake, and physical activity.
31 ipid-class fatty acid profile indicated that serum lipid alterations were localized to the cholestero
32 ism, located proximal to the IL28 gene, with serum lipid and apolipoprotein levels in 746 subjects wi
33 ription factor involved in the regulation of serum lipid and glucose levels, has recently been associ
36 w examines the effects of n-3 fatty acids on serum lipid and lipoprotein concentrations in seven spec
37 n apo E(-/-)/LDLR(-/-) mice had no effect on serum lipid and lipoprotein concentrations, although it
43 ytoin and carbamazepine produce increases in serum lipids and C-reactive protein, as well as decrease
46 icated many genes previously associated with serum lipids and found previously recognized association
48 iants across the genome for association with serum lipids and have generated novel hypotheses about t
50 ietary factors explain ethnic differences in serum lipids and insulin profiles in children, independe
51 low calorific value also beneficially lower serum lipids and lipid deposition in animals fed on athe
54 ents (85 type 1 and 139 type 2) and assessed serum lipids and lipoproteins from fasting blood, skin r
58 used to examine the effects of the diets on serum lipids and lipoproteins: AAD [34% fat; 16% saturat
59 ciated with health effects such as increased serum lipids and liver enzymes, decreased vaccine respon
62 Fasting blood sugar, serum insulin, fasting serum lipids and serum alanine aminotransferase (ALT) le
64 associated with incident CVD, independent of serum lipids and traditional CVD risk factors, in ethnic
67 easured by quantitative computed tomography, serum lipids, and endometrial effects as assessed by rat
68 subcutaneous adipose tissue, blood pressure, serum lipids, and fasting plasma glucose) were collected
69 (mostly mild or moderate), higher levels of serum lipids, and greater decreases from baseline in bon
70 by euglycemic clamp, blood pressure, fasting serum lipids, and insulin at mean 15 and 22 years of age
71 fects on arterial stiffness, blood pressure, serum lipids, and plasma PS concentrations were investig
73 In adults, high blood pressure (BP), adverse serum lipids, and smoking associate with cognitive defic
74 e greater with greater age, body mass index, serum lipids, and the use of supplements containing vita
77 rum lipids during therapy, determine whether serum lipids are associated with virological response, a
78 sults of this study support the concept that serum lipids are CHD risk factors in older Americans.
79 cause R,R-19a produced only a weak effect on serum lipids as compared with niacin, we conclude that t
80 ost severe steatosis and highest hepatic and serum lipids as well as insulin resistance among the eig
87 rculation longer in participants with higher serum lipids, but the (2)H-alpha-tocopherol absorbed was
88 f RCTs, coffee was associated with a rise in serum lipids, but this result was affected by significan
92 ND PARTICIPANTS: Cross-sectional analysis of serum lipid concentrations among 16,116 youths aged 6 to
93 onal data suggest there were improvements in serum lipid concentrations among US children and adolesc
97 in the relations between dietary factors and serum lipid concentrations by APOE polymorphism were ide
98 endpoints were the mean percentage change in serum lipid concentrations from baseline to week 12; the
100 the influence of esterified plant sterols on serum lipid concentrations in adults with mild-to-modera
102 ace-, sex-, and age-specific upper decile of serum lipid concentrations in children born with low bir
103 effect of dietary behenic acid (behenate) on serum lipid concentrations in humans is assumed to be ne
104 y factors were significantly associated with serum lipid concentrations in the directions expected ba
106 ir was associated with greater reductions in serum lipid concentrations than was continuation of lopi
107 988-1994 and 2007-2010, a favorable trend in serum lipid concentrations was observed among youths in
109 A 24-h diet recall was collected and fasting serum lipid concentrations were measured at all visits.
110 s included weight at 3, 6, and 12 months and serum lipid concentrations, blood pressure, urinary keto
111 t anterior descending coronary artery (LAD), serum lipid concentrations, serum thiocyanate (for smoki
114 cluded age, body mass index, blood pressure, serum lipids, diabetes, family history of myocardial inf
115 nhibitor studies and the transplant studies, serum lipids did not differ significantly between groups
118 viral therapy was associated with changes in serum lipids during and after antiviral therapy, with th
119 udy were to evaluate baseline and changes in serum lipids during therapy, determine whether serum lip
120 ion, adjusting for age, reference date year, serum lipids, education, race/ethnicity, smoking, and al
122 ng for age, body mass index, serum cotinine, serum lipids (except for PFCs), and study site (Michigan
124 e diets had no significant adverse effect on serum lipid, fasting serum glucose, and fasting serum in
125 fore and 6 weeks after the switch to measure serum lipid fractions, lipoprotein(a), C-reactive protei
126 analysis of 188 patients, changes in fasting serum lipids from baseline to month 12 were compared bet
127 of the cholesterol measures, statin use, or serum lipid genes and any of the AMD outcomes in the met
129 waist circumference, blood pressure, fasting serum lipids, glucose, and insulin were measured, and ov
131 DeltaEC mice had reduced adiposity, impaired serum lipid homeostasis, and a higher respiratory exchan
135 e effect of reasonable intakes of cashews on serum lipids in adults with or at risk of high LDL chole
136 ptor may have a role in regulating levels of serum lipids in animal models of obesity and insulin res
138 tion regarding the importance of the role of serum lipids in patients with elevated serum lipid level
140 Pre- and post fasting blood was drawn for serum lipid, insulin, 8-isoprostaglandin F(2alpha) (8-is
141 rols Hfe(-/-) mice exhibit no differences in serum lipid, insulin, glucagon, or thyroid hormone level
143 the relative proportion of omega-6 PUFAs in serum lipids is inversely related to the incidence of me
145 ilar approach involving standardization plus serum lipid level adjustment generally performed well.
148 ence creatinine (e.g., age and hydration) or serum lipid levels (e.g., body mass index and recent fat
149 possibly represent a return to preinfection serum lipid levels after accounting for expected age-rel
150 ination Survey has shown favorable trends in serum lipid levels among children and adolescents aged 6
152 The Yi farmers had the lowest age-adjusted serum lipid levels among the three groups, white the Yi
153 is also associated with favorable changes in serum lipid levels and an improvement in glycemic contro
155 idence that genetic variants associated with serum lipid levels and body mass index influence CAC lev
158 ntify novel loci predisposing to unfavorable serum lipid levels and coronary heart disease (CHD).
161 l gene transfer resulted in normalization of serum lipid levels and in the clearance of apo E-contain
164 the effects of experimentally induced IH on serum lipid levels and pathways of lipid metabolism in t
165 o be more than a casual relationship between serum lipid levels and systemic health (particularly car
166 and haplotypes are associated with elevated serum lipid levels and the metabolic syndrome (P = 0.008
168 o determine migration-related differences in serum lipid levels and to estimate the contribution of e
169 sults of this study suggest that ectopic and serum lipid levels are positively associated with bone m
170 oci have been reported to be associated with serum lipid levels at genome-wide statistical significan
171 4, fasting sample) for direct measurement of serum lipid levels before study treatments were started.
174 er adjustment for family medical history and serum lipid levels did not substantially change these re
175 lambda gene variant was also associated with serum lipid levels in chronic hepatitis C patients.
176 tive estrogen-receptor modulator, on fasting serum lipid levels in men receiving ADT for prostate can
179 steine was not significantly associated with serum lipid levels or family history of cardiovascular d
181 ly identification of novel regions linked to serum lipid levels that would have otherwise been missed
184 ceived that glucocorticoids adversely affect serum lipid levels, although results of prospective stud
192 nonblack race, higher body mass index, lower serum lipid levels, HIV replication, low nadir CD4(+) ce
193 gle-nucleotide polymorphisms associated with serum lipid levels, hypertension, and CAD and tested the
194 trated no beneficial changes in body weight, serum lipid levels, hypothyroid symptoms as measured by
195 c loci for coronary artery calcification and serum lipid levels, one of the strongest risk factors fo
196 erences in plasma post-heparin LPL activity, serum lipid levels, or lipoprotein distribution between
197 typic association with type 2 diabetes, BMI, serum lipid levels, serum adiponectin levels, and measur
198 fter adjusting for age, sex, smoking status, serum lipid levels, systemic and dietary factors, and CF
199 iple regression model adjusted for age, sex, serum lipid levels, years of smoking, and pack-years, ye
206 trols were 32 healthy men and women for whom serum lipid, lipoprotein, and cytokine concentrations we
207 th a variety of critical illnesses, for whom serum lipid, lipoprotein, and cytokine concentrations we
208 ical records indicated that the CR group had serum lipid-lipoprotein and BP levels in the usual range
210 nclude smoking cessation, exercise, lowering serum lipids, lowering high blood pressure, and daily an
211 in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diab
213 biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atheroscler
214 rine n-3 fatty acid) have similar effects on serum lipid markers at intakes recommended for primary p
215 ned to an intervention or control group, and serum lipids, markers of insulin sensitivity, and serum
218 l infarction; treatment-related increases in serum lipids may contribute to greater cardiovascular di
219 al periodontal parameters were measured, and serum lipids, MDA, and 8-OHdG levels were assessed in bl
220 nd 35 years were estimated by using repeated serum lipid measurements over 20 years in the CARDIA stu
223 secondary outcome measures included fasting serum lipids, microvascular reactivity, arterial stiffne
224 t understanding the mechanisms through which serum lipids modulate Abeta could offer new approaches t
225 of this study was to evaluate the effect on serum lipids of a yeast-derived beta-glucan fiber in 15
226 ecent observations concerning the effects of serum lipids on immune cell phenotype/function, and a he
227 asurement error bias caused by variations in serum lipids or by urinary diluteness, we recommend impr
229 care, there appeared to be little effect of serum lipids or statins on the incidence of proliferativ
231 rmal FA (and/or RD) in BD, and also examined serum lipid peroxidation (lipid hydroperoxides, LPH and
232 ned after 2 to 3 hours' postischemia and the serum lipid peroxide levels followed the same pattern.
233 B(1)) in liver plays a key role in increased serum lipid production, fatty liver, and possibly diet-i
235 designed to assess prospectively changes in serum lipid profile and myocardial perfusion with serial
236 stinct phenolic and fibre concentrations, on serum lipid profile and oxLDL of male Wistar rats fed a
238 aim was to determine the association between serum lipid profile and the incidence of radiographic ha
239 d dietary nutrient intake, the difference in serum lipid profile between the Yi migrants and the Yi f
240 m oxidative stress and improved (p<0.05) the serum lipid profile in the high-fat dietary groups; mean
243 psyllium seed husk (PSH)/d for 24 wk on the serum lipid profile were assessed in this randomized, do
245 0.10-1.45) but no improvement in the overall serum lipid profile, blood pressure, and glycemic contro
247 to IH for five days to determine changes in serum lipid profile, liver lipid content, and expression
249 estigated the association of SFA intake with serum lipid profiles and ASVD mortality in a population-
251 n on host metabolism, we examined changes in serum lipid profiles and intrahepatic expression of lipi
254 f target concentration, resulted in improved serum lipid profiles in kidney transplant recipients at
259 ession or knockdown of Tm6sf2 in mice alters serum lipid profiles, consistent with the association ob
260 ed with oral glucose tolerance tests (OGTT), serum lipid profiles, magnetic resonance imaging (MRI) f
261 0 single-nucleotide polymorphisms (SNPs), of serum lipid profiles, we identified a major linkage sign
265 ps of mice exhibited similar body weight and serum lipid profiles; however, both MKP-1(+/-) and MKP-1
266 Adverse effects include those on the liver, serum lipids, psyche/behavior and reproductive system.
268 hatidylcholine 18:0/18:1 (PC(18:0/18:1) as a serum lipid regulated by diurnal hepatic PPARdelta activ
270 CD4/CD8 ratio, smoking, comorbid conditions, serum lipids, renal function (estimated glomerular filtr
271 asis model assessment of insulin resistance, serum lipids, reproductive hormones, leptin, acylated gh
276 ociations between smoking, fish consumption, serum lipids, systemic and dietary factors, the CFH sing
278 l history, physical activity, adiposity, and serum lipids, the hazard ratio in the highest quartile w
279 mia due to its capacity to positively affect serum lipids to a greater extent than other currently ma
282 leotide polymorphisms associate with fasting serum lipid traits and whether the effects are modulated
283 f HCV-mediated upregulation of LDLR inhibits serum lipid uptake and thereby perturbs HCV replication.
284 ll, our findings highlight the importance of serum lipid uptake by infected hepatocytes in HCV life c
286 nd the catalogue of variants responsible for serum lipid variation and, with a full catalogue of vari
291 ntal area under the curve (AUCi) method, and serum lipids were determined with the use of standard as
294 Similarly, it is standard to adjust for serum lipids when measuring lipophilic chemicals in seru
295 gen agonist-like actions on bone tissues and serum lipids while displaying potent estrogen antagonist
297 ght-loss regimens have a favorable impact on serum lipids without the accompanying ketosis and have t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。